In Vitro Hematopoiesis In Myelodysplasia: Liquid and Soft-Gel Culture Studies (Q36244134)

13 August 2017

1 reference

title

In vitro hematopoiesis in myelodysplasia: liquid and soft-gel culture studies (English)

1 reference

13 August 2017

In Vitro Hematopoiesis In Myelodysplasia: Liquid and Soft-Gel Culture Studies (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

15 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

15 October 2022

Richert-Boe KE

1 reference

13 August 2017

Bagby GC Jr

series ordinal

1 reference

13 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1613005

15 October 2022

publication date

1 June 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:S0889858818303277?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

https://api.elsevier.com/content/article/PII:S0889858818303277?httpAccept=text/plain

15 October 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Hematology / Oncology Clinics of North America

15 October 2022

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

543-556

1 reference

Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia): identification of responsive patients using in-vitro techniques

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

T-lymphocyte--mediated granulopoietic failure. In vitro identification of prednisone-responsive patients.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

In vitro granulopoiesis in oligoblastic leukaemia: prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The growth of mouse bone marrow cells in vitro

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Treatment of RAEB-t with intensive chemotherapy and GM-CSF.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Prognostic Value of in Vitro Bone Marrow Culture in Refractory Anaemia with Excess of Myeloblasts

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Use of bone-marrow culture in prediction of acute leukaemic transformation in preleukaemia

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

"Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Identification of the colony-stimulating cell in human peripheral blood

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Human preleukemia. Identification of a maturation defect in vitro

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The preleukemic syndrome: correlation of in vitro parameters of granulopoiesis with clinical features

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Granulopoiesis in acute myeloid leukemia and preleukemia

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Megakaryocyte colony formation by bone marrow progenitors in myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Bone marrow cultures and prognosis in primary myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Developmental potential and dynamic behavior of hematopoietic stem cells.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

In vitro colony and cluster growth in haemopoietic dysplasia (the preleukaemic syndrome). II. Identification of a maturation defect in agar cultures.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Hematopoietic growth factors in bone marrow transplantation

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Bone Marrow Culture Studies in Refractory Cytopenia and ‘Smouldering Leukaemia’

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Hemopoietic stem cells: stochastic differentiation and humoral control of proliferation

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Humoral regulation of stem cell proliferation

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Growth response of human myeloid leukemia cells to colony-stimulating factors

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The cloning of normal ?Mast? cells in tissue culture

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Subgroups of oligoleukemia as identified by in vitro agar culture

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Colony-cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high-risk myelodysplasia

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Predictive value of bone marrow cultures in 48 patients with acute myeloblastic leukaemia or myelodysplasia both secondary to treatment of other malignant diseases

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

In vitro agar culture patterns in preleukemia and their clinical significance

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Stimulation of murine hemopoietic colony formation by human IL-6

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30327-7

15 October 2022

Identifiers

1 reference